The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody–Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment
The use of serum containing polyclonal antibodies from animals immunized with toxins marked the begi...
Immunotherapeutic monoclonal antibodies (mAbs) can be defined as those that exert their functions b...
Monoclonal antibodies (mAbs) and their directly derived cell-based application known as chimeric ant...
The book deals with therapeutic monoclonal antibodies (mAbs) broadly, and relevant topics such as ch...
Therapeutic monoclonal antibodies have emerged in the 1990 decade as an important option for cancer ...
This book is a compendium of scientific articles submitted to a Special Issue of International Journ...
Target therapy is the result of many years research dedicated to identify the characteristics of can...
Fundamentally, the therapy technique which is utilized in malignancy immunotherapy, monoclonal antib...
The developments of antibodies for cancer therapeutics have made remarkable success in recent years....
Monoclonal antibodies are established in clinical practice for the treatment of cancer, and autoimmu...
Monoclonal antibodies (mAbs) are among the most specialised molecules for the recognition and captur...
In recent years, monoclonal antibodies (mAbs), as potent antitumor tools, have gained increasing imp...
Research and development of antitumor monoclonal antibody agents have shown substantial progress. Mo...
Monoclonal antibodies (mAbs) are a group of antibodies produced by identical clones of B lymphocytes...
Monoclonal antibodies (mAbs) and their directly derived cell-based application known as chimeric ant...
The use of serum containing polyclonal antibodies from animals immunized with toxins marked the begi...
Immunotherapeutic monoclonal antibodies (mAbs) can be defined as those that exert their functions b...
Monoclonal antibodies (mAbs) and their directly derived cell-based application known as chimeric ant...
The book deals with therapeutic monoclonal antibodies (mAbs) broadly, and relevant topics such as ch...
Therapeutic monoclonal antibodies have emerged in the 1990 decade as an important option for cancer ...
This book is a compendium of scientific articles submitted to a Special Issue of International Journ...
Target therapy is the result of many years research dedicated to identify the characteristics of can...
Fundamentally, the therapy technique which is utilized in malignancy immunotherapy, monoclonal antib...
The developments of antibodies for cancer therapeutics have made remarkable success in recent years....
Monoclonal antibodies are established in clinical practice for the treatment of cancer, and autoimmu...
Monoclonal antibodies (mAbs) are among the most specialised molecules for the recognition and captur...
In recent years, monoclonal antibodies (mAbs), as potent antitumor tools, have gained increasing imp...
Research and development of antitumor monoclonal antibody agents have shown substantial progress. Mo...
Monoclonal antibodies (mAbs) are a group of antibodies produced by identical clones of B lymphocytes...
Monoclonal antibodies (mAbs) and their directly derived cell-based application known as chimeric ant...
The use of serum containing polyclonal antibodies from animals immunized with toxins marked the begi...
Immunotherapeutic monoclonal antibodies (mAbs) can be defined as those that exert their functions b...
Monoclonal antibodies (mAbs) and their directly derived cell-based application known as chimeric ant...